Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 1Nervous System Diseases 1Epilepsy 1Brain Neoplasms 1

Interventions

Specimen Handling 354Magnetic Resonance Spectroscopy 252Biopsy 222Nivolumab 69Cyclophosphamide 65Carboplatin 56Radiation 53Paclitaxel 53X-Rays 52pembrolizumab 51Taxes 51Immunoglobulin G 51Disulfides 51Cisplatin 49Platinum 451,2-diaminocyclohexaneplatinum II citrate 45Doxorubicin 44Radiotherapy 42Ipilimumab 38atezolizumab 37fludarabine 35Gemcitabine 35CTLA-4 Antigen 35olaparib 32Vincristine 31Prednisone 31Bevacizumab 30venetoclax 27Cytarabine 27Rituximab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Clinical Laboratory Techniques × 1 year × Clear all
NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡